Avoro Capital Advisors’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-440,000
| Closed | -$10.7M | – | 45 |
|
|
2021
Q1 | $10.7M | Sell |
440,000
-200,000
| -31% | -$4.85M | 0.18% | 41 |
|
|
2020
Q4 | $20.5M | Buy |
640,000
+37,500
| +6% | +$1.2M | 0.35% | 32 |
|
|
2020
Q3 | $18.2M | Buy |
602,500
+77,500
| +15% | +$2.34M | 0.26% | 37 |
|
|
2020
Q2 | $22.1M | Buy |
525,000
+3,250
| +0.6% | +$137K | 0.44% | 32 |
|
|
2020
Q1 | $13M | Buy |
+521,750
| New | +$13M | 0.44% | 30 |
|